At the recent BioPartner Forum it was stated the internal market is insufficient for a UK Life Science company to develop a technology, product or service at a rate that will return investor value. Do you
Medilink UK welcomes Gordon Browns announcment following the budget that there will be a minister for life sciences if labour win the election but what would we want him or her to achieve on behalf of our industry
